Recent studies showed that the same mutation (rs149617956, E318K) identified on MITF, has been reported as associated with a high risk of melanoma, renal cell carcinoma and pancreatic cancer (Gromowski et al., 2014; Sturm et al., 2014). Here, MITF is linked to renal cell carcinoma.